Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion

Scandinavian Journal of Rheumatology

Volumn 38, Issue 4, 2009, Pages 282-290

  Van Lieshout, A W T ^a   Vonk, M C ^a   Bredie, S J H ^a   Joosten, L B A ^a   Netea, M G ^a   Van Riel, P L C M ^a   Lafyatis, R ^b   Van Den Hoogen, F H J ^a   Radstake, T R D J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Arthritis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CHEMOKINE CCL18; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CHO CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINES, CC; CRICETINAE; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MONOCYTES; PROBABILITY; RAYNAUD DISEASE; REFERENCE VALUES; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4;

EID: 70350647257     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802572467     Document Type: Article

References (40)

1. Sakkas LI, Platsoucas CD. Is systemic sclerosis an antigendriven T cell disease? Arthritis Rheum 2004;50:1721-1733
2. Mavalia C, Scaletti C, Romagnani P, Carossibo AM, Pignone A, Emmi L, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997;151:1751-1758
3. Annunziato F, Cosmi L, Galli G, Beltrame C, Romagnani P, Maneti R, et al. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol 1999;65:691-699
4. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997;24:328-332
5. Kucharz EJ, Brzezinska-Wcislo L, Kotulska A, Gasiorowska- Kielkowska W, Gozdzik J. Elevated serum level of interleukin- 10 in patients with systemic sclerosis. Clin Rheumatol 1997;16:638-639
6. Atamas SP, White B. The role of chemokines in the pathogenesis of scleroderma. Curr Opin Rheumatol 2003;15:772-777
7. Fujii H, Shimada Y, HasegawaM, Takehara K, Sato S. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci 2004;35:43-51.
8. Adema GJ, Hartgers F, Verstraten R, De Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997;387:713-717
9. Hieshima K, Imai T, Baba M. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997;159:1140-1149
10. Kodelja V, Muller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CCchemokine- 1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998;160:1411-1418
11. Van Lieshout AW, Van der Voort R, le Blanc LM, Roelofs MF, Schreurs BW, Van Riel PL, et al. Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid. BMC Immunol 2006;7:23.
12. Van Der Voort R, Kramer M, Lindhout E, Figdor CG, Adema GJ. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions. J Leukoc Biol 2005;77:739-747
13. Vissers JL, Hartgers FC, Lindhout E, Teunissen MB, Figdor CG, Adema GJ. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2001;69:785-793 (Pubitemid 32466418)
14. Atamas SP, Luzina IG, Choi J, Tsymbulyuk N, Carbonetti NH, Singh IS, et al. Pulmonary and activationregulated chemokine stimulates collagen production in lung fibroblasts. Am J Respir Cell Mol Biol 2003;29:743-749
15. Luzina IG, Tsymbalyuk N, Choi J, Hasday JD, Atamas SP. CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. J Cell Physiol 2005;206:221-228
16. Kodera M, Hasegawa M, Komura K, Yanaba K, Takehara K, Sato S. Serum pulmonary and activation-regulated chemokine/ CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosis. Arthritis Rheum 2005;52:2889-2896
17. Prasse A, Pechkovsky DV, Toews GB, Schafer M, Eggeling S, Ludwig C, et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 2007;56:1685-1693
18. Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 2002;26:549-557
19. Radstake TR, van Lent PL, Pesman GJ, Blom AB, Sweep FG, Ronnelid J, et al. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. Ann Rheum Dis 2004;63:696-702.
20. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, Van Lieshout AW, Sprong T, Van Den Hoogen FH, et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005;52:2313-2322
21. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99:351-358
22. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-305
23. Roelofs MF, Abdollahi-Roodsaz S, Joosten LA, Van Den Berg WB, Radstake TR. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 2008;58:338-348
24. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, Van Zoelen MA. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042-1049
25. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590
26. LeRoy EC, Black C, Fleischmajer R. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205
27. Clements PJ, Lachenbruch PA, Seibold JR. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-1896
28. Radstake TR, Blom AB, Sloetjes AW, van Gorselen EO, Pesman GJ, Engelen L, et al. Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis. Ann Rheum Dis 2004;63:1556-1563
29. Radstake TR, Van Der Voort R, Ten Brummelhuis M, De Waal Malefijt M, Looman M, Figdor CG, Van Den Berg WB, et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis and regulation by Fc gamma receptors. Ann Rheum Dis 2005;64:359-367
30. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000;105:497-504.
31. Netea MG, Kullberg BJ, De Jong DJ, Franke B, Sprong T, Naber TH, Van Der Meer JWM. NOD2 mediates antiinflammatory signals induced by TLR2 ligands: Implications for Crohn's disease. Eur J Immunol 2004;34:2052-2059
32. Van Lieshout AW, Barrera P, Smeets RL, Adema GJ, Figdor CG, Van Den Berg WB, et al. Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: A potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis. Ann Rheum Dis 2005;64:408-414
33. Radstake TR, Van Lent PL, Pesman GJ, Blom AB, Sweep FG, Ronnelid J, et al. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. Ann Rheum Dis 2004;63:696-702.
34. Roelofs MF, Boelens WC, Joosten LA, Van Den Berg WB, Van Riel PL, Radstake TR. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006;176:7021-7027
35. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008;9:632-640
36. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, Soumelis V. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008;9:650-657
37. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332
38. Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol 2008;20:68-74.
39. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007;13:851-856
40. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008;58:1465-1474